FDA okays RIVANNA’s AI-powered Accuro XV ultrasound system
The clearance marks a pivotal step forward for the company as it pushes deeper into AI-driven diagnostics and expands its clinical footprint in point-of-care imaging
The clearance marks a pivotal step forward for the company as it pushes deeper into AI-driven diagnostics and expands its clinical footprint in point-of-care imaging
The ultrasound-based AI imaging platform is designed to support rapid fracture detection and soft tissue injury assessment in emergency care settings
Facility marks cornerstone of $50 billion investment in medicines R&D and manufacturing in America
Subscribe To Our Newsletter & Stay Updated